日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis

三联疗法(磷酸克林霉素 1.2%/阿达帕林 0.15%/过氧化苯甲酰 3.1%)治疗痤疮:一项汇总的 3 期分析的疗效和安全性

Kircik, Leon H; Stein Gold, Linda; Gold, Michael; Weiss, Jonathan S; Harper, Julie C; Del Rosso, James Q; Bunick, Christopher G; Bhatia, Neal; Tanghetti, Emil A; Eichenfield, Lawrence F; Baldwin, Hilary; Draelos, Zoe D; Callender, Valerie D; Han, George; Gooderham, Melinda J; Sadick, Neil; Lupo, Mary P; Lain, Edward Ted; Werschler, William Philip

Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug

克林霉素磷酸酯1.2%、过氧化苯甲酰3.1%和阿达帕林0.15%固定剂量凝胶治疗中重度痤疮的疗效和安全性:首个三联药物的随机II期研究

Stein Gold, Linda; Baldwin, Hilary; Kircik, Leon H; Weiss, Jonathan S; Pariser, David M; Callender, Valerie; Lain, Edward; Gold, Michael; Beer, Kenneth; Draelos, Zoe; Sadick, Neil; Pillai, Radhakrishnan; Bhatt, Varsha; Tanghetti, Emil A

Oxymetazoline and Energy-Based Therapy in Patients with Rosacea: Evaluation of the Safety and Tolerability in an Open-Label, Interventional Study

羟甲唑啉联合能量疗法治疗酒渣鼻患者:一项开放标签干预研究的安全性和耐受性评估

Tanghetti, Emil A; Goldberg, David J; Dover, Jeffrey S; Geronemus, Roy G; Bai, Zane; Alvandi, Nancy; Shanler, Stuart D

Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel

关于玫瑰痤疮诊断、分类和治疗的建议:2019 年全球玫瑰痤疮共识小组的最新进展

Schaller, M; Almeida, L M C; Bewley, A; Cribier, B; Del Rosso, J; Dlova, N C; Gallo, R L; Granstein, R D; Kautz, G; Mannis, M J; Micali, G; Oon, H H; Rajagopalan, M; Steinhoff, M; Tanghetti, E; Thiboutot, D; Troielli, P; Webster, G; Zierhut, M; van Zuuren, E J; Tan, J

Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study

一项随机、双盲、平行组、对照研究显示,新型固定剂量复方制剂阿达帕林0.3%/过氧化苯甲酰2.5%凝胶单药治疗可有效治疗中重度炎症性寻常痤疮。

Stein Gold, Linda; Weiss, Jonathan; Rueda, Maria Jose; Liu, Hong; Tanghetti, Emil

Sialic acid associated with αvβ3 integrin mediates HIV-1 Tat protein interaction and endothelial cell proangiogenic activation

与 αvβ3 整合素相关的唾液酸介导 HIV-1 Tat 蛋白相互作用和内皮细胞促血管生成激活

Paola Chiodelli, Chiara Urbinati, Stefania Mitola, Elena Tanghetti, Marco Rusnati

The combination of Ezetimibe and Statin: a new treatment for hypercholesterolemia

依泽替米贝联合他汀类药物:高胆固醇血症的新疗法

Nodari, Savina; Rocca, Patrizia; Saporetti, Alberto; Bettari, Luca; Foresti, Anna Lucia; Tanghetti, Elena; Metra, Marco; Dei Cas, Livio

Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2

细胞膜GM1神经节苷脂是成纤维细胞生长因子2的功能性辅助受体。

Rusnati, Marco; Urbinati, Chiara; Tanghetti, Elena; Dell'Era, Patrizia; Lortat-Jacob, Hugues; Presta, Marco

Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures

成纤维细胞生长因子-2 (FGF-2) 与游离神经节苷脂的相互作用:内皮细胞培养中的生化特征和生物学后果

Rusnati, M; Tanghetti, E; Urbinati, C; Tulipano, G; Marchesini, S; Ziche, M; Presta, M

A distinct basic fibroblast growth factor (FGF-2)/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells

一种独特的碱性成纤维细胞生长因子 (FGF-2)/FGF 受体相互作用可将尿激酶型纤溶酶原激活剂的诱导作用与内皮细胞的促有丝分裂作用区分开来。

Rusnati, M; Dell'Era, P; Urbinati, C; Tanghetti, E; Massardi, M L; Nagamine, Y; Monti, E; Presta, M